Veralto Co. (NYSE:VLTO) Shares Sold by AMG National Trust Bank

AMG National Trust Bank cut its position in shares of Veralto Co. (NYSE:VLTO) by 31.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 2,136 shares of the company’s stock after selling 978 shares during the period. AMG National Trust Bank’s holdings in Veralto were worth $239,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund boosted its holdings in shares of Veralto by 0.5% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 18,861 shares of the company’s stock valued at $1,801,000 after buying an additional 100 shares during the period. Tokio Marine Asset Management Co. Ltd. raised its position in shares of Veralto by 1.4% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 7,338 shares of the company’s stock worth $821,000 after purchasing an additional 100 shares during the period. Strategic Blueprint LLC lifted its holdings in shares of Veralto by 4.5% in the 3rd quarter. Strategic Blueprint LLC now owns 2,394 shares of the company’s stock worth $268,000 after purchasing an additional 102 shares during the last quarter. Graypoint LLC increased its holdings in shares of Veralto by 2.4% in the 3rd quarter. Graypoint LLC now owns 4,514 shares of the company’s stock worth $505,000 after acquiring an additional 107 shares during the period. Finally, Sentry Investment Management LLC lifted its position in Veralto by 1.8% in the 3rd quarter. Sentry Investment Management LLC now owns 5,999 shares of the company’s stock valued at $671,000 after purchasing an additional 108 shares during the last quarter. Institutional investors and hedge funds own 91.28% of the company’s stock.

Veralto Trading Up 1.1 %

NYSE:VLTO opened at $103.98 on Wednesday. The business’s 50-day moving average price is $108.44 and its two-hundred day moving average price is $104.26. Veralto Co. has a 1-year low of $70.47 and a 1-year high of $115.00. The firm has a market capitalization of $25.72 billion and a price-to-earnings ratio of 32.09. The company has a current ratio of 2.13, a quick ratio of 1.87 and a debt-to-equity ratio of 1.35.

Veralto (NYSE:VLTO) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $0.89 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.04. The business had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.30 billion. Veralto had a net margin of 15.69% and a return on equity of 52.85%. The firm’s quarterly revenue was up 4.7% on a year-over-year basis. During the same period last year, the business posted $0.75 earnings per share. On average, equities analysts expect that Veralto Co. will post 3.48 earnings per share for the current year.

Veralto Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Shareholders of record on Friday, September 27th were given a dividend of $0.09 per share. This represents a $0.36 annualized dividend and a dividend yield of 0.35%. The ex-dividend date was Friday, September 27th. Veralto’s dividend payout ratio (DPR) is 11.11%.

Insiders Place Their Bets

In other Veralto news, SVP Surekha Trivedi sold 753 shares of Veralto stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $111.10, for a total value of $83,658.30. Following the completion of the transaction, the senior vice president now directly owns 11,918 shares of the company’s stock, valued at $1,324,089.80. The trade was a 5.94 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jennifer Honeycutt sold 13,191 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $111.98, for a total transaction of $1,477,128.18. Following the sale, the chief executive officer now directly owns 138,546 shares of the company’s stock, valued at approximately $15,514,381.08. This trade represents a 8.69 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 28,639 shares of company stock valued at $3,175,803. 0.31% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have weighed in on VLTO shares. Royal Bank of Canada lifted their target price on Veralto from $108.00 to $111.00 and gave the company a “sector perform” rating in a research note on Friday, October 25th. Stifel Nicolaus increased their price objective on Veralto from $117.00 to $119.00 and gave the company a “buy” rating in a research report on Wednesday, October 16th. UBS Group initiated coverage on shares of Veralto in a report on Tuesday, August 13th. They issued a “neutral” rating and a $118.00 target price for the company. The Goldman Sachs Group increased their target price on Veralto from $104.00 to $116.00 and gave the company a “buy” rating in a report on Monday, July 29th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Veralto from $100.00 to $109.00 and gave the company a “hold” rating in a research report on Monday, July 29th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $108.27.

Veralto Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.